PLIVA Acquires Uso Racional in Spain
Advertisement
PLIVA d.d. announced that an agreement has been signed with Novartis' generics division, Sandoz, for the purchase of its Spanish subsidiary Uso Racional S.L (UR) for a total cash consideration of EUR 21.5m. With expected sales of about EUR 12m in 2006, UR represents a well known and established generics brand in Spain, with a small dedicated sales force and a complementary product portfolio and attractive pipeline. The acquisition of UR represents a strong strategic fit with PLIVA's current Spanish operations, which PLIVA expects to help it significantly strengthen its position and performance on this market.
Advertisement